Have your say on the Federal Register of Legislation. Complete our annual survey and tell us about your experience using the Register. The survey closes on 28 November 2026.
This item is authorised by the following title:
Food Standards (Application A1339 – 2′-FL, 3-FL, LNT, 3′-SL and 6′-SL from Escherichia coli BL21 for use as nutritive substances in infant formula products) Variation (F2026L01127)
Food Standards (Proposal P1065 – Code Revision – 2025 Amendments (Compositional requirements for Special Medical Purpose Product for infants and other miscellaneous amendments)) Variation (F2026L00481)
Food Standards (Application A1324 – 3-fucosyllactose as a nutritive substance in infant formula products) Variation (F2026L00022)
Food Standards (Application A1307 – Milk fat globule membrane as a nutritive substance in infant formula products) Variation (F2025L00857)
Food Standards (Application A1300 Vitamin K2 (as Menaquinone-7) as a permitted form of Vitamin K in FSMP) Variation (F2025L00163)
Food Standards (Proposal P1028 – Infant Formula – Consequential Amendments) Variation (F2024L01151)
Food Standards (Application A1265 – 2'-FL/DFL, LNT, 6'-SL sodium salt and 3'-SL sodium salt as nutritive substances in infant formula products) Variation (F2023L01561)
Food Standards (Application A1253 – Bovine Lactoferrin in Infant Formula Products) Variation (F2023L00452)
Food Standards (Application A1230 – Very Low Energy Diets (VLED)) Variation (F2022L00733)
Food Standards (Application A1190 – 2'-FL in infant formula and other products)Variation (F2022L00038)
View Explanatory Statement/s